EP1409656A4 - Screening von nichtpeptidischen, nichtsteroiden pheromonverbindungen von invertebraten auf eine mitogenaktivierte proteinkinase modulierende aktivität - Google Patents

Screening von nichtpeptidischen, nichtsteroiden pheromonverbindungen von invertebraten auf eine mitogenaktivierte proteinkinase modulierende aktivität

Info

Publication number
EP1409656A4
EP1409656A4 EP01916541A EP01916541A EP1409656A4 EP 1409656 A4 EP1409656 A4 EP 1409656A4 EP 01916541 A EP01916541 A EP 01916541A EP 01916541 A EP01916541 A EP 01916541A EP 1409656 A4 EP1409656 A4 EP 1409656A4
Authority
EP
European Patent Office
Prior art keywords
invertebrate
mitogen
steroid
peptide
protein kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01916541A
Other languages
English (en)
French (fr)
Other versions
EP1409656A1 (de
Inventor
Nadav Zamir
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darley Pharmaceuticals Ltd
Original Assignee
Darley Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darley Pharmaceuticals Ltd filed Critical Darley Pharmaceuticals Ltd
Publication of EP1409656A1 publication Critical patent/EP1409656A1/de
Publication of EP1409656A4 publication Critical patent/EP1409656A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01916541A 2001-03-12 2001-03-12 Screening von nichtpeptidischen, nichtsteroiden pheromonverbindungen von invertebraten auf eine mitogenaktivierte proteinkinase modulierende aktivität Withdrawn EP1409656A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/007687 WO2002072809A1 (en) 2001-03-12 2001-03-12 Screening non-peptide, non-steroid invertebrate pheromone compounds for mitogen-activated protein kinase modulating activity

Publications (2)

Publication Number Publication Date
EP1409656A1 EP1409656A1 (de) 2004-04-21
EP1409656A4 true EP1409656A4 (de) 2005-01-12

Family

ID=21742389

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01916541A Withdrawn EP1409656A4 (de) 2001-03-12 2001-03-12 Screening von nichtpeptidischen, nichtsteroiden pheromonverbindungen von invertebraten auf eine mitogenaktivierte proteinkinase modulierende aktivität

Country Status (3)

Country Link
EP (1) EP1409656A4 (de)
AU (1) AU2001243556A1 (de)
WO (1) WO2002072809A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861745A1 (fr) * 2003-10-31 2005-05-06 Centre Nat Rech Scient Ligands du repressseur mycobacterien ethr, procedes de selection et applications

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0099572A1 (de) * 1982-07-20 1984-02-01 Phillips Petroleum Company Disproportionierung von funktionalisierten Olefinen
EP0544391A1 (de) * 1991-09-02 1993-06-02 Teva Pharmaceutical Industries, Ltd. Zusammensetzungen für lokale Behandlungen von Schuppenflechten und atopischer Dermatitis
WO1996022985A1 (en) * 1995-01-24 1996-08-01 Warner-Lambert Company 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders
US5750129A (en) * 1992-08-28 1998-05-12 Phero Tech Inc. Composite polymer matrices for controlled release of semiochemicals
EP0896819A1 (de) * 1996-01-31 1999-02-17 Sergei Dmitrievich Burlakov Medikament auf basis von antiglucocorticoid
WO2001039766A2 (en) * 1999-12-01 2001-06-07 Alydar Pharmaceuticals Ltd. Screening invertebrate pheromones for therapeutic activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677834B2 (en) * 1993-04-07 1997-05-08 Cancer Research Ventures Limited Methods for screening of substances for therapeutic activityand yeast for use therein
US5981265A (en) * 1993-04-15 1999-11-09 National Jewish Center For Immunology And Respiratory Medicine Methods for regulating MEKK protein activity
US5728376A (en) * 1995-04-25 1998-03-17 Cornell Research Foundation, Inc. Tetradecatrienyl and tetradecadienyl acetates and their use as sex attractants for tomato pests
US5663313A (en) * 1996-06-28 1997-09-02 Incyte Pharmaceuticals, Inc. Human map kinase homolog
DE69731960T2 (de) * 1996-09-24 2005-12-15 Cadus Pharmaceutical Corp. Verfahren und zusammensetzungen für die identifizierung von receptor effectoren
US6165461A (en) * 1998-04-14 2000-12-26 Board Of Regents, University Of Texas System Tao protein kinases and methods of use therefor

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0099572A1 (de) * 1982-07-20 1984-02-01 Phillips Petroleum Company Disproportionierung von funktionalisierten Olefinen
EP0544391A1 (de) * 1991-09-02 1993-06-02 Teva Pharmaceutical Industries, Ltd. Zusammensetzungen für lokale Behandlungen von Schuppenflechten und atopischer Dermatitis
US5750129A (en) * 1992-08-28 1998-05-12 Phero Tech Inc. Composite polymer matrices for controlled release of semiochemicals
WO1996022985A1 (en) * 1995-01-24 1996-08-01 Warner-Lambert Company 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders
EP0896819A1 (de) * 1996-01-31 1999-02-17 Sergei Dmitrievich Burlakov Medikament auf basis von antiglucocorticoid
WO2001039766A2 (en) * 1999-12-01 2001-06-07 Alydar Pharmaceuticals Ltd. Screening invertebrate pheromones for therapeutic activity

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CASTIONI P ET AL: "VOLATILE CONSTITUENTS FROM BRUNFELSIA GRANDIFLORA SSP. GRANDIFLORA: QUALITATIVE ANALYSIS BY GC-MS", SCIENTIA PHARMACEUTICA, OESTERREICHISCHE APOTHEKER VERLAGSGESELLSCHAFT,, AT, vol. 64, no. 1, 1996, pages 83 - 91, XP009032813, ISSN: 0036-8709 *
HARVEY D J: "PYRIDINE-CONTAINING SCHIFF BASE DERIVATIVES FOR THE STRUCTURAL DETERMINATION OF LONG-CHAIN ALDEHYDES BY GAS CHROMATOGRAPHY COMBINED WITH MASS SPECTROMETRY", JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, ELSEVIER SCIENCE INC., NEW YORK, NY, US, vol. 2, no. 3, 1991, pages 245 - 249, XP009030705, ISSN: 1044-0305 *
KAAE R S ET AL: "SEX PHEROMONES OF LEPIDOPTERA. XXXVII. ROLE OF SEX PHEROMONES AND OTHER FACTORS IN REPRODUCTIVE ISOLATION AMONG TEN SPECIES OF NOCTUIDAE", ANNALS OF THE ENTOMOLOGICAL SOCIETY OF AMERICA, ENTOMOLOGICAL SOCIETY OF AMERICA, COLLEGE PARK, MD, US, vol. 66, no. 2, 1973, pages 444 - 448, XP009030704, ISSN: 0013-8746 *
MUHAYIMANA A ET AL: "CHEMICAL COMPOSITION OF ESSENTIAL OILS OF SOME MEDICINAL PLANTS FROM RWANDA", JOURNAL OF ESSENTIAL OIL RESEARCH, XX, XX, vol. 10, no. 3, May 1998 (1998-05-01), pages 251 - 259, XP009032814, ISSN: 1041-2905 *
REGNIER F E ET AL: "INSECT PHEROMONES BEE REV", JOURNAL OF LIPID RESEARCH, vol. 9, no. 5, 1968, pages 541 - 551, XP002279531, ISSN: 0022-2275 *
See also references of WO02072809A1 *
TILLMAN JULIE A ET AL: "Insect pheromones-An overview of biosynthesis and endocrine regulation", INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 29, no. 6, June 1999 (1999-06-01), pages 481 - 514, XP002279532, ISSN: 0965-1748 *

Also Published As

Publication number Publication date
AU2001243556A1 (en) 2002-09-24
EP1409656A1 (de) 2004-04-21
WO2002072809A8 (en) 2002-10-10
WO2002072809A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
MX258385B (es) Quinazolina(di)onas para control de plagas de invertebrados.
GB2394104B (en) Pattern cross-matching
MXPA02007609A (es) Disposicion cribadora.
EP1395112A4 (de) Eiersammelvorrichtung
HUP0401882A3 (en) Substrate for epitaxy
GB0311822D0 (en) System for controlling streamers
AUPR279101A0 (en) Protein kinase signalling
GB0229596D0 (en) Pest control
IL144583A0 (en) Chimeric protein kinase inhibitors
MXPA03009676A (es) CONTROL DE COMPACTIBILIDAD A TRAVeS DE CRISTALIZACION.
AU2001243556A1 (en) Screening non-peptide, non-steroid invertebrate pheromone compounds for mitogen-activated protein kinase modulating activity
GB0130252D0 (en) An improved horticultural hedgetrimmer
GB9803399D0 (en) Protein kinase c
MXPA03007646A (es) Plaguicida sinergico.
AU2003299029A1 (en) Substituted phosphonate compounds having bone anabolic activity
NO20013354D0 (no) Vekstfremmende middel
AU2003271951A8 (en) Kinase modulation assay
GB0108395D0 (en) Insole cushioning system
AU2003286181A1 (en) Phosphorylated ndr kinase
GB0214688D0 (en) Fishing aid
AU2002350570A1 (en) Protein with kinase activity
GB0130242D0 (en) Multi planter
GB0101332D0 (en) Egg holder
GB0218480D0 (en) Pest control system
GB0117810D0 (en) Novel egg charectors

Legal Events

Date Code Title Description
PUAJ Public notification under rule 129 epc

Free format text: ORIGINAL CODE: 0009425

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040112

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DARLEY PHARMACEUTICALS LTD.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/231 B

Ipc: 7A 61K 31/121 B

Ipc: 7A 61K 31/11 B

Ipc: 7A 61K 31/045 B

Ipc: 7A 61K 31/015 B

Ipc: 7C 12Q 1/48 A

A4 Supplementary search report drawn up and despatched

Effective date: 20041124

17Q First examination report despatched

Effective date: 20050223

17Q First examination report despatched

Effective date: 20050223

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070604